Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Fleming

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Annals of Surgical Oncology|January 1, 1994
Ability of low-dose cyclophosphamide to overcome metastasis-induced immunosuppressionT M Tuttle, M D Fleming, P S Hogg, et al.
Genes & Development|March 29, 2001
A mutation in a mitochondrial transmembrane protein is responsible for the pleiotropic hematological and skeletal phenotype of flexed-tail (f/f) miceM D Fleming, D R Campagna, J N Haslett, et al.
Blood|July 27, 2000
The molecular defect in hypotransferrinemic miceC C Trenor, D R Campagna, V M Sellers, et al.
Blood|September 10, 1998
The G185R mutation disrupts function of the iron transporter Nramp2M A Su, C C Trenor, J C Fleming, et al.
Blood|June 25, 1999
The C282Y mutation causing hereditary hemochromatosis does not produce a null alleleJ E Levy, L K Montross, D E Cohen, et al.
Blood|February 13, 2001
Expression of the DMT1 (NRAMP2/DCT1) iron transporter in mice with genetic iron overload disordersF Canonne-Hergaux, J E Levy, M D Fleming, et al.
Oncogene|June 10, 2014
SIRT3 regulates cellular iron metabolism and cancer growth by repressing iron regulatory protein 1S M Jeong, J Lee, L W S Finley, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 1998
Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transportM D Fleming, M A Romano, M A Su, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1995
Adoptive transfer of bryostatin-activated tumor-sensitized lymphocytes prevents or destroys tumor metastases without expansion in vitroM D Fleming, H D Bear, K Lipshy, et al.
Molecular Cell|October 17, 1998
p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activitiesA Yang, M Kaghad, Y Wang, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Annals of Surgical Oncology|January 1, 1994
Ability of low-dose cyclophosphamide to overcome metastasis-induced immunosuppressionT M Tuttle, M D Fleming, P S Hogg, et al.
Genes & Development|March 29, 2001
A mutation in a mitochondrial transmembrane protein is responsible for the pleiotropic hematological and skeletal phenotype of flexed-tail (f/f) miceM D Fleming, D R Campagna, J N Haslett, et al.
Blood|July 27, 2000
The molecular defect in hypotransferrinemic miceC C Trenor, D R Campagna, V M Sellers, et al.
Blood|September 10, 1998
The G185R mutation disrupts function of the iron transporter Nramp2M A Su, C C Trenor, J C Fleming, et al.
Blood|June 25, 1999
The C282Y mutation causing hereditary hemochromatosis does not produce a null alleleJ E Levy, L K Montross, D E Cohen, et al.
Blood|February 13, 2001
Expression of the DMT1 (NRAMP2/DCT1) iron transporter in mice with genetic iron overload disordersF Canonne-Hergaux, J E Levy, M D Fleming, et al.
Oncogene|June 10, 2014
SIRT3 regulates cellular iron metabolism and cancer growth by repressing iron regulatory protein 1S M Jeong, J Lee, L W S Finley, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 1998
Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transportM D Fleming, M A Romano, M A Su, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1995
Adoptive transfer of bryostatin-activated tumor-sensitized lymphocytes prevents or destroys tumor metastases without expansion in vitroM D Fleming, H D Bear, K Lipshy, et al.
Molecular Cell|October 17, 1998
p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activitiesA Yang, M Kaghad, Y Wang, et al.
Pageof 4